Connect Biopharma Hldgs Analyst Price Targets

Wall Street analyst price targets and consensus rating for Connect Biopharma Hldgs (CNTB).

Price Target Range — 11 Quarters

Analyst Consensus — 7 Analysts

7Buy

Consensus RatingBuy# Analysts7Avg. Consensus PT$6Upside to Avg. PT+593.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 8, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$7
Oct 2, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$7
Sep 30, 2026	BTIG	Julian Harrison	PT Cut	Buy	$10→$5
Sep 22, 2026	Oppenheimer	Mazahir Alimohamed	PT Cut	Outperform	$8→$5
Sep 17, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$7
Sep 16, 2026	Canaccord Genuity	Edward Nash	PT Cut	Buy	$7→$6
Sep 15, 2026	BTIG	Julian Harrison	Maintained	Buy	$10
Jul 9, 2026	Oppenheimer	Mazahir Alimohamed	Initiate	Outperform	$8
Jun 26, 2026	Piper Sandler	Biren Amin	Initiate	Neutral→Overweight	$7
Jun 25, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$7
May 26, 2026	Canaccord Genuity	Edward Nash	Initiate	Buy	$6
May 21, 2026	Cantor Fitzgerald	Olivia Brayer	Initiate	Overweight	$4
Apr 1, 2026	BTIG	Julian Harrison	Maintained	Buy	$10
Mar 31, 2026	BTIG	Julian Harrison	Maintained	Buy	$10
Dec 1, 2025	Lake Street	Thomas Flaten	Initiate	Buy	$9
Nov 13, 2025	BTIG	Julian Harrison	Maintained	Buy	$10
Oct 31, 2025	BTIG	Julian Harrison	Initiate	Buy	$10
Aug 13, 2025	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$7
Jun 12, 2025	HC Wainwright & Co.	Brandon Folkes	Assumes	Buy	$7
Apr 1, 2025	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$8

Benzinga Newsdesk

Benzinga Newsdesk

Benzinga Newsdesk

Benzinga Newsdesk

Benzinga Newsdesk

Benzinga Newsdesk